Reducing High Risk Behavior in Drug Court
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in drug courts.
| Condition | Intervention | Phase |
|---|---|---|
|
Substance Abuse HIV |
Behavioral: Computer-facilitated HIV intervention Behavioral: Attention Control |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention |
| Official Title: | Delivering HIV Risk Reduction Services in Drug Court |
- engagement in high risk behaviors [ Time Frame: 15 month follow-up ] [ Designated as safety issue: No ]Measured by the Risk Assessment Battery (RAB)
- rate of HIV testing [ Time Frame: 15 month follow-up ] [ Designated as safety issue: Yes ]
- Condom Procurement [ Time Frame: 15 month follow-up ] [ Designated as safety issue: Yes ]
- Self-reported Condom Use [ Time Frame: 15 month follow-up ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 400 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Attention Control |
Behavioral: Attention Control
Life skills training DVDs that match the duration of the anticipated experimental condition. The DVDs address topics such as positive listening skills, anger management, and stress reduction.
|
| Experimental: Computer-facilitated HIV intervention |
Behavioral: Computer-facilitated HIV intervention
Individuals assigned to the experimental condition will complete the self-directed CARE HIV intervention during each of their first three sessions. The 20 minute intervention sessions involve several components including a brief risk assessment, review of identified risks, structured skill building videos, and the development of a risk prevention action plan. Because of the adaptive nature of the CARE program, the content of each session will be tailored to address the current risks of the participant. While the main focus of the intervention is on risk, individuals who report being HIV infected will receive a referral to treatment if they are not currently receiving medical care and their session will address, among other things, adherence to HIV care.
|
Detailed Description:
Four hundred consenting felony drug court participants will be randomly assigned to either an HIV intervention group (n = 200) or an attention control group. All clients will attend their regularly scheduled status hearings which are scheduled approximately every six weeks. Clients in the HIV intervention group will receive a brief computerized, self-administered HIV risk reduction intervention following each of their first three status hearings. Clients in the attention control condition will view a series of educational life-skill videos of matched length following each of their first three status hearings. The primary outcome will be engagement in high risk behaviors as measured by the Risk Assessment Battery (RAB). Secondary HIV-related outcomes will include: (1) rate of HIV testing, (2) condom procurement, and (3) self-reported condom use. Tertiary outcomes related to drug court compliance will include: (1) drug court graduation, (2) urinalysis-confirmed drug abstinence, (3) case management attendance, and (4) satisfaction with case management. In addition, we will conduct preliminary cost and cost-effectiveness analyses on the delivery of the brief computerized HIV intervention. Assessments will be conducted at baseline and 9- and 15-months post admission.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- be at least 18 years of age;
- be charged with a non-violent felony offense
- have no more than two prior non-violent convictions or diversionary opportunities
- be willing to participate in the drug court program for at least 12 months
- be in need of treatment for drug abuse or dependence as assessed by case management.
Exclusion Criteria:
- Elderly subjects and those with medical problems will be included in the research as long as they do not have any physical or psychiatric condition that would impede their ability to give competent consent to research participation or to understand the research instruments.
- Those individuals who are intoxicated, cognitively impaired, or psychiatrically unstable when approached will not be included; however, such individuals may subsequently be included if the disqualifying condition subsides.
- Spanish speaking only individuals.
- Client remanded to jail or residential treatment facilities at the time of Treatment Court enrollment.
Contacts and Locations| Contact: David S Festinger, Ph.D. | 215-399-0980 ext 126 | dfestinger@tresearch.org |
| Contact: Karen Dugosh, Ph.D. | 215-399-0980 ext 104 | kdugosh@tresearch.org |
| United States, Pennsylvania | |
| Philadelphia Treatment Court | Recruiting |
| Philadelphia, Pennsylvania, United States, 19107 | |
| Contact: David S Festinger, Ph.D. 215-399-0980 ext 126 dfestinger@tresearch.org | |
| Contact: Caitlin Ryan, BA 2153990980 ext 121 cryan@tresearch.com | |
| Principal Investigator: David S Festinger, Ph.D. | |
| Sub-Investigator: Karen Dugosh, Ph.D. | |
| Principal Investigator: | David S Festinger, Ph.D. | Treatment Research Institute |
More Information
No publications provided
| Responsible Party: | Treatment Research Institute |
| ClinicalTrials.gov Identifier: | NCT01481428 History of Changes |
| Other Study ID Numbers: | #1002, R01DA030257 |
| Study First Received: | November 18, 2011 |
| Last Updated: | December 13, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Treatment Research Institute:
|
High risk behavior Drug court clients Substance abuse HIV intervention |
Additional relevant MeSH terms:
|
Substance-Related Disorders Mental Disorders |
ClinicalTrials.gov processed this record on March 14, 2013
